BTIG Research lowered shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, Marketbeat Ratings reports.
Other equities analysts have also issued reports about the stock. StockNews.com upgraded shares of Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a research report on Friday, September 20th. B. Riley began coverage on shares of Tactile Systems Technology in a research note on Thursday, September 26th. They set a “buy” rating and a $23.00 target price on the stock.
Read Our Latest Stock Report on TCMD
Tactile Systems Technology Price Performance
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.10 by $0.10. The firm had revenue of $73.22 million for the quarter, compared to analysts’ expectations of $72.62 million. Tactile Systems Technology had a return on equity of 9.38% and a net margin of 5.42%. Sell-side analysts predict that Tactile Systems Technology will post 0.64 earnings per share for the current year.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Arcadia Investment Management Corp MI bought a new stake in shares of Tactile Systems Technology during the third quarter valued at approximately $29,000. Quarry LP bought a new stake in Tactile Systems Technology in the 2nd quarter valued at $46,000. Magnetar Financial LLC purchased a new stake in Tactile Systems Technology in the 2nd quarter worth $130,000. SG Americas Securities LLC bought a new position in shares of Tactile Systems Technology during the 3rd quarter valued at about $156,000. Finally, Sequoia Financial Advisors LLC purchased a new position in shares of Tactile Systems Technology during the first quarter valued at about $166,000. 83.43% of the stock is owned by hedge funds and other institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Further Reading
- Five stocks we like better than Tactile Systems Technology
- Market Cap Calculator: How to Calculate Market Cap
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What is a Secondary Public Offering? What Investors Need to Know
- Insider Buying Signals Upside for These 3 Stocks
- What is a Death Cross in Stocks?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.